CUE

Cue Biopharma, Inc.

Healthcare · Biotechnology

$299.91 sample

+4.27 (+1.44%) 1D

Market cap

$1.77T

Price as of

2026-10-24

Latest filing

8-K · 2026-10-06

Alerts

8

Price$299.91 +11.64% 3M daily closessample

299.91263.58

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: Chief Financial Officer
Oct 14INSInsider sell: 10% owner
Oct 06SECDEF 14A filed
Sep 29INSInsider sell: General Counsel
Sep 23INSInsider sell: Director
Sep 16INSInsider buy: Chief Executive Officer
Sep 10INSInsider buy: Chief Executive Officer
Sep 02INSInsider sell: Chief Executive Officer

Sign up to see the real CUE record →

Company facts

SEC EDGAR registration

Name: Cue Biopharma, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -45sample, -100 to +100
Reporting currency: USD

Who is positioning in CUE

sample

Insiders: 24 insider transactions over 90 days, net selling, $11.4M
Congress: 2 members traded over 90 days
Institutions · 13F: 25 funds hold $40.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$39.1B +15.5% y/y

Q4 2024Q3 2026

Inventory$23.6B +6.3% y/y

Q4 2024Q3 2026

Accounts receivable$17.9B +10.8% y/y

Q4 2024Q3 2026

Total debt$48.3B +13.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $763.1B -11.3% 3M
Sample peer B: $763.2B -12.7% 3M
Sample peer C: $1.45T +3.2% 3M
Sample peer D: $241.8B +15.6% 3M
Sample peer E: $626.0B +9.7% 3M